Tag:

Moderna

FDA Limits Access To New COVID-19 Vaccines: Here's What To Know FDA Limits Access To New COVID-19 Vaccines: Here's What To Know
FDA Limits Access To New Covid-19 Vaccines: Here's What To Know As fall approaches, the Food and Drug Administration has authorized updated COVID-19 vaccines from both Pfizer-BioNTech and Moderna, but with access limited to those most at risk for severe illness. On Wednesday, Aug. 27, the FDA approved the 2025-2026 formulas from both companies, each tailored to target the LP.8.1 sublineage — a new offshoot of the JN.1 Omicron variant — aligning the vaccines with the strains currently circulating in the US.  Pfizer-BioNTech’s COMIRNATY LP.8.1 is approved for adults 65 and older, as well as individuals ages 5 to 64 with at least one underlying health…
Moderna Slashing Hundreds Of Jobs As COVID-19 Vaccine Sales Slow Moderna Slashing Hundreds Of Jobs As COVID-19 Vaccine Sales Slow
Moderna Slashing Hundreds Of Jobs As Covid-19 Vaccine Sales Slow Vaccine manufacturer Moderna will lay off hundreds of employees about five years after it rose to prominence during the COVID-19 pandemic. The layoffs make up about 10% of Moderna's global workforce, CEO Stéphane Bancel said in a staff memo on Thursday, July 31. The Cambridge, Massachusetts, biotech firm is trying to cut $1.5 billion in annual operating expenses by 2027. Bancel said the job cuts are a "necessary step forward" for the company. "This decision was not made lightly," he wrote. "It impacts teammates and friends who have dedicated themselves to our mission an…
COVID-19: Hochul Urges NYers To Receive New Vaccines Ahead Of Flu Season COVID-19: Hochul Urges NYers To Receive New Vaccines Ahead Of Flu Season
Covid-19: Hochul Urges NYers To Receive New Vaccines Ahead Of Flu Season Now that the new COVID-19 vaccine is available in New York, Gov. Kathy Hochul is urging residents to get their updated shots ahead of this year's respiratory virus illness season. Related story - COVID-19: New XEC Strain 'Just Getting Started' Sparks Concern Amid Summer Wave Of US Cases In an announcement this week, Hochul encouraged eligible New Yorkers to get the new Food and Drug Administration-approved vaccine for the 2024-2025 season, offered by Pfizer, Moderna, and Novavax.  According to Hochul, receiving the new vaccine is more pressing as students return to school and …